查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1908507

美國器官捐贈和移植軟體市場規模、佔有率和趨勢分析報告：按軟體類型、部署類型、應用、最終用途和細分市場預測（2026-2033 年）

U.S. Organ Donation And Transplant Software Market Size, Share & Trends Analysis Report By Software Type, By Deployment Mode (Cloud-based, On-premise), By Application (Organ Donation Workflow Automation), By End-use, And Segment Forecasts, 2026 - 2033
出版日期: | 出版商: Grand View Research | 英文 90 Pages | 商品交期: 2-10個工作天內

價格

美國器官捐贈與移植軟體市場概覽

2025年美國器官捐贈和移植軟體市場規模估計為5,716萬美元，預計2033年將達到9,004萬美元。

預計從 2026 年到 2033 年，該行業將以 5.9% 的複合年成長率成長。這一成長是由器官移植數量和需求的增加、終末期器官疾病患病率的上升、標準化數據報告和註冊提交的監管要求以及快速準確地進行供體-受體匹配的需求所驅動的。

美國器官移植數量的不斷成長顯著加速了器官捐贈和移植軟體的普及應用。根據美國器官捐贈者聯合網路（UNOS）統計，2024年美國器官移植手術數量超過48,000例，較2015年成長55%，凸顯了美國器官移植事業規模的不斷擴大和複雜性的日益增加。這種成長給器官捐贈組織（OPO）和移植中心帶來了巨大壓力，包括管理大規模的捐贈者庫、更頻繁地進行配型、加快決策週期以及管理日益複雜的後勤工作流程。因此，亟需先進的軟體解決方案來簡化捐贈者管理、實現分配和配型自動化、提高資料準確性、確保合規性並支援整個移植生態系統的即時協作。

在美國，標準化數據報告和提交至註冊機構的監管要求是器官捐贈和移植軟體市場的主要驅動力。移植中心、器官獲取組織 (OPO) 和組織配型檢查室必須向國家機構（如 OPTN/UNOS 和 HRSA）提交全面及時的臨床、運營和結果數據，包括捐贈者特徵、匹配實踐、器官捐贈、移植事件和長期移植後隨訪。

這些強制性報告要求，以及嚴格的審核追蹤、品質指標和合規標準，催生了對能夠自動收集數據、確保準確性、與電子健康記錄 (EHR) 和實驗室系統保持互通性並簡化註冊提交流程的軟體平台的需求。日益嚴格的監管審查和對數據透明度的更高期望，正促使各機構採用先進的數位化解決方案，以減輕行政負擔、避免合規漏洞，並確保在整個移植過程中報告的一致性和標準化。

美國醫療保健人工智慧整合器官捐贈和移植軟體市場

人工智慧在器官捐贈和移植工作流程的應用，正推動美國先進數位平台的廣泛普及。移植中心和器官捐贈組織（OPO）越來越依賴智慧工具來提高供受者配對的準確性、加快決策速度並改善整體移植效果。人工智慧能夠實現預測分析、自動風險評分、快速數據處理以及臨床和營運團隊之間的高效協作。 LifeFuser 是 Ataims Tech 公司推出的安全、基於雲端的 AI 驅動型移植管理平台，旨在最佳化器官移植工作流程，包括供受者配對和即時分析。

腎臟、肝臟、心臟、肺臟和胰臟移植計畫透過預測結果模型、客製化工作流程和全面的資料整合，為器官移植的各個階段提供支持，同時確保符合 HIPAA 和 GDPR 法規。這類平台展現了人工智慧如何重塑移植手術流程，並推動美國器官捐贈和移植軟體市場的成長。

目錄

第1章調查方法和範圍

第2章執行摘要

第3章 市場變數、趨勢與範圍

  • 市場趨勢展望
  • 市場動態
  • 商業環境分析
    • 波特五力分析
    • PESTLE分析

第4章美國器官捐贈和移植軟體市場：按軟體類型分類的預測和趨勢分析

  • 按軟體類型分類的市佔率變化分析（2025 年和 2033 年）
  • 按軟體類型分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 器官捐贈管理系統
  • 移植管理系統
  • 器官分配與匹配平台
  • 器官取得及物流軟體
  • 其他（註冊資料管理系統等）

第5章：美國器官捐贈和移植軟體市場——按部署類型分類、估算和趨勢分析

  • 按安裝類型分類的市場佔有率變化分析（2025 年和 2033 年）
  • 按實施類型分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 基於雲端的
  • 本地部署

第6章：美國器官捐贈和移植軟體市場按應用、估算和趨勢分析

  • 按應用領域分類的市佔率變化分析（2025 年和 2033 年）
  • 按應用領域分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 器官捐贈工作流程自動化
  • 等候名單和接收者管理
  • 移植協調和日程安排
  • 監理報告合規性
  • 結果數據分析

第7章美國器官捐贈和移植軟體市場：按最終用途分類的估算和趨勢分析

  • 按最終用途分類的市佔率變化分析（2025 年和 2033 年）
  • 按最終用途分類的市場規模、預測和趨勢分析（2021-2033 年）
  • 醫院及移植中心
  • 器官獲取組織（OPO）
  • 國家和地方衛生組織
  • 研究和學術機構

第8章 競爭情勢

  • 企業市場分析
  • 公司分類
  • 公司簡介/列表
    • InVita Healthcare Technologies
    • XVIVO
    • CareDx
    • Afflo
    • Ataims Tech
    • MedSleuth, Inc.
    • EDITLife
    • Buckeye Transplant Solutions
    • United Network for Organ Sharing
Product Code: GVR-4-68040-838-6

U.S. Organ Donation And Transplant Software Market Summary

The U.S organ donation and transplant software market size was estimated at USD 57.16 million in 2025 and is projected to reach USD 90.04 million by 2033, growing at a CAGR of 5.9% from 2026 to 2033. This growth is attributed to the increasing organ transplant volumes and demand, growing prevalence of end-stage organ diseases, regulatory requirements for standardized data reporting and registry submission, and need for faster, more accurate donor-recipient matching.

Increasing organ transplant volumes in the U.S. are significantly accelerating the adoption of organ donation and transplant software. According to United Network for Organ Sharing, more than 48,000 organ transplants were performed in the U.S. in 2024, with a 55% increase in transplant procedures since 2015, highlighting the expanding scale and complexity of national transplant operations. This rise places substantial pressure on OPOs and transplant centers to manage larger donor pools, higher match-run frequencies, faster decision cycles, and more intricate logistics workflows. As a result, advanced software solutions are increasingly required to streamline donor management, automate allocation and matching, enhance data accuracy, ensure regulatory compliance, and support real-time coordination across the entire transplant ecosystem.

Regulatory requirements for standardized data reporting and registry submission are a major driver of the U.S. organ donation and transplant software market. Transplant centers, OPOs, and histocompatibility labs must submit comprehensive and timely clinical, operational, and outcome data to national bodies such as the OPTN/UNOS and the HRSA, covering donor characteristics, match runs, organ offers, transplant events, and long-term post-transplant follow-up.

These mandatory reporting obligations, along with strict audit trails, quality metrics, and compliance standards, create a need for software platforms that can automate data capture, ensure accuracy, maintain interoperability with EHRs and laboratory systems, and streamline registry submissions. As regulatory scrutiny and data transparency expectations continue to increase, organizations are turning to advanced digital solutions to reduce administrative burden, avoid compliance gaps, and ensure consistent, standardized reporting across the transplant continuum.

Integration of AI in U.S. Healthcare Organ Donation & Transplant Software market

The integration of AI into organ donation and transplant workflows is driving strong adoption of advanced digital platforms in the U.S., as transplant centers and OPOs increasingly rely on intelligent tools to improve donor-recipient matching accuracy, accelerate decision-making, and enhance overall transplant outcomes. AI enables predictive analytics, automated risk scoring, faster data processing, and more efficient coordination across clinical and operational teams. LifeFuser is a secure, cloud-based AI-driven transplant management platform by Ataims Tech designed to optimize organ transplant workflows, including donor-recipient matching and real-time analytics.

It supports all phases of organ transplantation with predictive outcome modeling, customizable workflows, and comprehensive data integration across kidney, liver, heart, lung, and pancreas programs, while ensuring HIPAA and GDPR compliance. Such platforms demonstrate how AI is reshaping transplant operations and contributing to the growth of the U.S. organ donation and transplant software market.

U.S. Healthcare Organ Donation And Transplant Software Market Report Segmentation

This report forecasts revenue growth at regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the U.S. healthcare organ donation and transplant software market report based software type, deployment mode, application, and end-use:

  • Software Type Outlook (Revenue, USD Million, 2021 - 2033)
  • Organ Donor Management Systems
  • Transplant Management Systems
  • Organ Allocation & Matching Platforms
  • Organ Procurement & Logistics Software
  • Others
  • Deployment Mode Outlook (Revenue, USD Million, 2021 - 2033)
  • Cloud-based
  • On-premise
  • Application Outlook (Revenue, USD Million, 2021 - 2033)
  • Organ Donation Workflow Automation
  • Waitlist & Recipient Management
  • Transplant Coordination & Scheduling
  • Regulatory Reporting & Compliance
  • Outcome & Data Analytics
  • End-use Outlook (Revenue, USD Million, 2021 - 2033)
  • Hospitals & Transplant Centers
  • Organ Procurement Organizations (OPOs)
  • National/Regional Health Agencies
  • Research & Academic Institutes

Table of Contents

Chapter 1. Methodology and Scope

  • 1.1. Market Segmentation & Scope
  • 1.2. Segment Definitions
    • 1.2.1. Software Type
    • 1.2.2. Deployment Mode
    • 1.2.3. Application
    • 1.2.4. End use
  • 1.3. Estimates and Forecast Timeline
  • 1.4. Research Methodology
  • 1.5. Information Procurement
    • 1.5.1. Purchased Database
    • 1.5.2. GVR's Internal Database
    • 1.5.3. Secondary Sources
    • 1.5.4. Primary Research
  • 1.6. Information Analysis
    • 1.6.1. Data Analysis Models
  • 1.7. Market Formulation & Data Visualization
  • 1.8. Model Details
    • 1.8.1. Commodity Flow Analysis
  • 1.9. List of Secondary Sources
  • 1.10. Objectives

Chapter 2. Executive Summary

  • 2.1. Market Snapshot
  • 2.2. Segment Snapshot
  • 2.3. Competitive Landscape Snapshot

Chapter 3. Market Variables, Trends, & Scope

  • 3.1. Market Lineage Outlook
  • 3.2. Market Dynamics
    • 3.2.1. Market Driver Analysis
      • 3.2.1.1. Increasing organ transplant volumes and demand
      • 3.2.1.2. Growing prevalence of end-stage organ diseases
      • 3.2.1.3. Regulatory requirements for standardized data reporting and registry submission
      • 3.2.1.4. Need for faster, more accurate donor-recipient matching
    • 3.2.2. Market Restraint Analysis
      • 3.2.2.1. High implementation and maintenance costs of advanced software platforms.
      • 3.2.2.2. Limited IT infrastructure and digital readiness in smaller hospitals or OPOs.
    • 3.2.3. Industry Opportunity Analysis
    • 3.2.4. Industry Challenge Analysis
    • 3.2.5. Technology Overview
    • 3.2.6. Regulatory Overview
  • 3.3. Business Environment Analysis
    • 3.3.1. Porter's Five Forces Analysis
      • 3.3.1.1. Supplier power
      • 3.3.1.2. Buyer power
      • 3.3.1.3. Substitution threat
      • 3.3.1.4. Threat of new entrant
      • 3.3.1.5. Competitive rivalry
    • 3.3.2. PESTLE Analysis
      • 3.3.2.1. Political landscape
      • 3.3.2.2. Economic and Social landscape
      • 3.3.2.3. Technological landscape
      • 3.3.2.4. Environmental landscape
      • 3.3.2.5. Legal Landscape

Chapter 4. U.S. Organ Donation and Transplant Software Market: Software Type Estimates & Trend Analysis

  • 4.1. Solution Segment Dashboard
  • 4.2. Solution Market Share Movement Analysis, 2025 & 2033
  • 4.3. Market Size & Forecasts and Trend Analysis, by Solution, 2021 to 2033 (USD Million)
  • 4.4. Organ Donor Management Systems
    • 4.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.5. Transplant Management Systems
    • 4.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.6. Organ Allocation & Matching Platforms
    • 4.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.7. Organ Procurement & Logistics Software
    • 4.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 4.8. Others (Registry & Data Management System, etc.)
    • 4.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. U.S. Organ Donation and Transplant Software Market: Deployment Mode Estimates & Trend Analysis

  • 5.1. Deployment Mode Segment Dashboard
  • 5.2. Deployment Mode Market Share Movement Analysis, 2025 & 2033
  • 5.3. Market Size & Forecasts and Trend Analysis, by End Use, 2021 to 2033 (USD Million)
  • 5.4. Cloud-based
    • 5.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 5.5. On-premise
    • 5.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. U.S. Organ Donation and Transplant Software Market: Application Estimates & Trend Analysis

  • 6.1. Application Segment Dashboard
  • 6.2. Application Market Share Movement Analysis, 2025 & 2033
  • 6.3. Market Size & Forecasts and Trend Analysis, by Application, 2021 to 2033 (USD Million)
  • 6.4. Organ Donation Workflow Automation
    • 6.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.5. Waitlist & Recipient Management
    • 6.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.6. Transplant Coordination & Scheduling
    • 6.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.7. Regulatory Reporting & Compliance
    • 6.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 6.8. Outcome & Data Analytics
    • 6.8.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. U.S. Healthcare Organ Donation and Transplant Software Market: End Use Estimates & Trend Analysis

  • 7.1. End use Segment Dashboard
  • 7.2. End use Market Share Movement Analysis, 2025 & 2033
  • 7.3. Market Size & Forecasts and Trend Analysis, by End use, 2021 to 2033 (USD Million)
  • 7.4. Hospitals & Transplant Centers
    • 7.4.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.5. Organ Procurement Organizations (OPOs)
    • 7.5.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.6. National/Regional Health Agencies
    • 7.6.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 7.7. Research & Academic Institutes
    • 7.7.1. Market Revenue Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Competitive Landscape

  • 8.1. Company Market Position Analysis
  • 8.2. Company Categorization
  • 8.3. Company Profiles/Listing
    • 8.3.1. InVita Healthcare Technologies
      • 8.3.1.1. Participant Overview
      • 8.3.1.2. Financial performance
      • 8.3.1.3. Product benchmarking
      • 8.3.1.4. Strategic initiatives
    • 8.3.2. XVIVO
      • 8.3.2.1. Participant Overview
      • 8.3.2.2. Financial performance
      • 8.3.2.3. Product benchmarking
      • 8.3.2.4. Strategic initiatives
    • 8.3.3. CareDx
      • 8.3.3.1. Participant Overview
      • 8.3.3.2. Financial performance
      • 8.3.3.3. Product benchmarking
      • 8.3.3.4. Strategic initiatives
    • 8.3.4. Afflo
      • 8.3.4.1. Participant Overview
      • 8.3.4.2. Financial performance
      • 8.3.4.3. Product benchmarking
      • 8.3.4.4. Strategic initiatives
    • 8.3.5. Ataims Tech
      • 8.3.5.1. Participant Overview
      • 8.3.5.2. Financial performance
      • 8.3.5.3. Product benchmarking
      • 8.3.5.4. Strategic initiatives
    • 8.3.6. MedSleuth, Inc.
      • 8.3.6.1. Participant Overview
      • 8.3.6.2. Financial performance
      • 8.3.6.3. Product benchmarking
      • 8.3.6.4. Strategic initiatives
    • 8.3.7. EDITLife
      • 8.3.7.1. Participant Overview
      • 8.3.7.2. Financial performance
      • 8.3.7.3. Product benchmarking
      • 8.3.7.4. Strategic initiatives
    • 8.3.8. Buckeye Transplant Solutions
      • 8.3.8.1. Participant Overview
      • 8.3.8.2. Financial performance
      • 8.3.8.3. Product benchmarking
      • 8.3.8.4. Strategic initiatives
    • 8.3.9. United Network for Organ Sharing
      • 8.3.9.1. Participant Overview
      • 8.3.9.2. Financial performance
      • 8.3.9.3. Product benchmarking
      • 8.3.9.4. Strategic initiatives

List of Tables

  • Table 1. List of secondary sources
  • Table 2. List of abbreviations
  • Table 3. U.S. Healthcare Organ Donation & Transplant Software market, by software type, 2021 - 2033 (USD Million)
  • Table 4. U.S. Healthcare Organ Donation & Transplant Software market, by deployment model, 2021 - 2033 (USD Million)
  • Table 5. U.S. Healthcare Organ Donation & Transplant Software market, by application, 2021 - 2033 (USD Million)
  • Table 6. U.S. Healthcare Organ Donation & Transplant Software market, by end use, 2021 - 2033 (USD Million)

List of Figures

  • Fig. 1 Market research process
  • Fig. 2 Data triangulation techniques
  • Fig. 3 Market formulation & validation
  • Fig. 4 U.S. Organ Donation & Transplant Software market: Market outlook
  • Fig. 5 U.S. Organ Donation & Transplant Software market: Segment outlook
  • Fig. 6 U.S. Organ Donation & Transplant Software market: Competitive landscape outlook
  • Fig. 7 Parent market outlook
  • Fig. 8 U.S. Organ Donation & Transplant Software Market Driver Impact
  • Fig. 9 U.S. Organ Donation & Transplant Software market Restraint impact
  • Fig. 10 U.S. Organ Donation & Transplant Software market, Software Type outlook key takeaways (USD Million)
  • Fig. 11 U.S. Organ Donation & Transplant Software market: Software Type movement analysis (USD Million)
  • Fig. 12 Organ Donor Management Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 13 Transplant Management Systems market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 14 Organ Allocation & Matching Platforms market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 15 Organ Procurement & Logistics Software market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 16 Others (Registry & Data Management System, etc.) market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 17 Healthcare Organ Donation & Transplant Software market, Deployment Mode outlook key takeaways (USD Million)
  • Fig. 18 Healthcare Organ Donation & Transplant Software market: Deployment Mode movement analysis (USD Million)
  • Fig. 19 Cloud-based market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 20 On-premise market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 21 U.S. Organ Donation & Transplant Software market, Application outlook key takeaways (USD Million)
  • Fig. 22 U.S. Organ Donation & Transplant Software market: Application Mode movement analysis (USD Million)
  • Fig. 23 Organ Donation Workflow Automation market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 24 Waitlist & Recipient Management market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 25 Transplant Coordination & Scheduling market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 26 Regulatory Reporting & Compliance market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 27 Outcome & Data Analytics market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 28 U.S. Organ Donation & Transplant Software market, End Use outlook key takeaways (USD Million)
  • Fig. 29 U.S. Organ Donation & Transplant Software market: End Use Mode movement analysis (USD Million)
  • Fig. 30 Hospitals & Transplant Centers market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 31 Organ Procurement Organizations (OPOs market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 32 National/Regional Health Agencies market estimates and forecasts, 2021 - 2033 (USD Million)
  • Fig. 33 Research & Academic Institutes market estimates and forecasts, 2021 - 2033 (USD Million)